Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of V-01 Booster After Inactivated Vaccines
NCT05239832Phase 2Unknown
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Aug 2021
- Primary completion
- Sep 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of V-01 in coronavirus disease 2019 (COVID-19), sponsored by Livzon Pharmaceutical Group Inc.. Status: unknown.
02
Drugs
V-01
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05239832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05239832.